{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:02:01Z","timestamp":1791928921821,"version":"4.3.4"},"reference-count":43,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"5","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2026,5,21]]},"DOI":"10.1167\/iovs.67.5.59","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T13:30:44Z","timestamp":1779370244000},"page":"59","source":"Crossref","is-referenced-by-count":0,"title":["Risk of Glaucoma Progression in Patients Using a Calcium Channel Blocker: A Propensity-Matched Cohort Study"],"prefix":"10.1167","volume":"67","author":[{"given":"Ibrahim","family":"Qozat","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Mayo Clinic, Jacksonville, Florida, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazan","family":"Abubaker","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Mayo Clinic, Jacksonville, Florida, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranav","family":"Vasu","sequence":"additional","affiliation":[{"name":"Department of Medicine, Creighton University School of Medicine, Phoenix, Arizona, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella V.","family":"Wagner","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Mayo Clinic, Jacksonville, Florida, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Dorairaj","sequence":"additional","affiliation":[{"name":"Department of Medicine, Charles E. Schmidt College of Medicine, Boca Raton, Florida, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary V.","family":"Lang","sequence":"additional","affiliation":[{"name":"Mayo Clinic Alix School of Medicine, Jacksonville, Florida, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darby D.","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Mayo Clinic, Jacksonville, Florida, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syril","family":"Dorairaj","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Mayo Clinic, Jacksonville, Florida, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: a review","volume":"311","author":"Weinreb","year":"2014","journal-title":"JAMA"},{"key":"bib2","first-page":"887","article-title":"Glaucoma is second leading cause of blindness globally","volume":"82","author":"Kingman","year":"2004","journal-title":"Bull World Health Organ"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.optom.2016.02.003","article-title":"Glaucoma history and risk factors","volume":"10","author":"McMonnies","year":"2017","journal-title":"J Optom"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1016\/j.ophtha.2007.03.047","article-title":"Systemic antihypertensive medication and incident open-angle glaucoma","volume":"114","author":"M\u00fcskens","year":"2007","journal-title":"Ophthalmology"},{"issue":"Suppl 1","key":"bib5","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.survophthal.2008.08.006","article-title":"Risk factors for glaucoma onset and progression","volume":"53","author":"Coleman","year":"2008","journal-title":"Surv Ophthalmol"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/IJG.0000000000001964","article-title":"Multiple systemic vascular risk factors are associated with low-tension glaucoma","volume":"31","author":"Funk","year":"2022","journal-title":"J Glaucoma"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"102938","DOI":"10.1016\/j.media.2023.102938","article-title":"Gamma challenge: glaucoma grading from multi-modality images","volume":"90","author":"Wu","year":"2023","journal-title":"Med Image Anal"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/IJG.0b013e31821dac66","article-title":"Comparison of visual field severity classification systems for glaucoma","volume":"21","author":"Ng","year":"2012","journal-title":"J Glaucoma"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.survophthal.2006.12.008","article-title":"Staging functional damage in glaucoma: review of different classification methods","volume":"52","author":"Brusini","year":"2007","journal-title":"Surv Ophthalmol"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12880-018-0273-5","article-title":"Automatic differentiation of glaucoma visual field from non-glaucoma visual field using deep convolutional neural network","volume":"18","author":"Li","year":"2018","journal-title":"BMC Med Imaging"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1001\/jamaophthalmol.2023.3877","article-title":"Calcium channel blocker use and associated glaucoma and related traits among UK Biobank participants","volume":"141","author":"Kastner","year":"2023","journal-title":"JAMA Ophthalmol"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.ophtha.2023.05.001","article-title":"Association of systemic medication use with glaucoma and intraocular pressure: the European Eye Epidemiology Consortium","volume":"130","author":"Vergroesen","year":"2023","journal-title":"Ophthalmology"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.ophtha.2018.01.007","article-title":"Systemic medication associations with presumed advanced or uncontrolled primary open-angle glaucoma","volume":"125","author":"Zheng","year":"2018","journal-title":"Ophthalmology"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41433-019-0603-z","article-title":"A review of systemic medications that may modulate the risk of glaucoma","volume":"34","author":"Wu","year":"2020","journal-title":"Eye (Lond)"},{"issue":"Suppl 1","key":"bib17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2165\/00129784-200707001-00003","article-title":"Calcium channel blockers: differences between subclasses","volume":"7","author":"Frishman","year":"2007","journal-title":"Am J Cardiovasc Drugs"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00424-014-1454-x","article-title":"T-type calcium channel blockers as neuroprotective agents","volume":"466","author":"Kopecky","year":"2014","journal-title":"Pflugers Arch"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1527-3466.2002.tb00084.x","article-title":"Efonidipine hydrochloride: a dual blocker of L- and T-type Ca(2+) channels","volume":"20","author":"Tanaka","year":"2002","journal-title":"Cardiovasc Drug Rev"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/S0146-2806(99)90000-2","article-title":"Current status of calcium channel blockers in patients with cardiovascular disease","volume":"24","author":"Freher","year":"1999","journal-title":"Curr Probl Cardiol"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1111\/jch.14709","article-title":"Amlodipine in the current management of hypertension","volume":"25","author":"Wang","year":"2023","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"e13152","DOI":"10.1097\/MD.0000000000013152","article-title":"Blood pressure lowering effect of calcium channel blockers on perioperative hypertension: a systematic review and meta-analysis","volume":"97","author":"Lin","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ogla.2024.06.003","article-title":"Long-term systemic use of calcium channel blockers and incidence of primary open-angle glaucoma","volume":"7","author":"Tavakoli","year":"2024","journal-title":"Ophthalmol Glaucoma"},{"key":"bib25","first-page":"1144","article-title":"Effects of nilvadipine, a calcium antagonist, on rabbit ocular circulation and optic nerve head circulation in NTG subjects","volume":"40","author":"Tomita","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/S0002-9394(14)71458-8","article-title":"Calcium channel blockers in the management of low-tension and open-angle glaucoma","volume":"115","author":"Netland","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1089\/jop.2009.0005","article-title":"Comparative study of topical application of timolol and verapamil in patients with glaucoma within 6 months","volume":"25","author":"Shayegan","year":"2009","journal-title":"J Ocul Pharmacol Ther"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"W163","DOI":"10.7326\/0003-4819-147-8-200710160-00010-w1","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration","volume":"147","author":"Vandenbroucke","year":"2007","journal-title":"Ann Intern Med"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jclinepi.2016.04.014","article-title":"Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses","volume":"79","author":"Hern\u00e1n","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/pds.1357","article-title":"Immortal time bias in observational studies of drug effects","volume":"16","author":"Suissa","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1167\/iovs.63.13.3","article-title":"Blood pressure measures and incident primary open-angle glaucoma","volume":"63","author":"Macri","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1080\/08164622.2021.1964332","article-title":"Mechanistic links between systemic hypertension and open angle glaucoma","volume":"105","author":"Cui","year":"2022","journal-title":"Clin Exp Optom"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.ajo.2010.01.018","article-title":"Blood flow in glaucoma discussion. Blood pressure, perfusion pressure, and glaucoma","volume":"149","author":"Caprioli","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.ajo.2014.05.029","article-title":"The association of blood pressure and primary open-angle glaucoma: a meta-analysis","volume":"158","author":"Zhao","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ogla.2025.03.002","article-title":"Association of systemic calcium channel blocker use with visual field progression in a large real-world cohort from glaucoma clinics","author":"Montesano","year":"2025","journal-title":"Ophthalmol Glaucoma"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"16224","DOI":"10.1038\/s41598-023-43420-3","article-title":"Effect of antihypertensive medications on the risk of open-angle glaucoma","volume":"13","author":"Lee","year":"2023","journal-title":"Sci Rep"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1185\/03007990903035083","article-title":"Effect of selected antihypertensives, antidiabetics, statins and diuretics on adjunctive medical treatment of glaucoma: a population based study","volume":"25","author":"Iskedjian","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"144B","DOI":"10.1016\/0002-9149(85)90623-X","article-title":"Calcium-channel blockers: effects on cerebral blood flow and potential uses for acute stroke","volume":"55","author":"Gelmers","year":"1985","journal-title":"Am J Cardiol"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1136\/bjophthalmol-2014-306093","article-title":"Calcium channel blockade reduces mechanical strain-induced extracellular matrix gene response in lamina cribrosa cells","volume":"99","author":"Quill","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.ajo.2010.09.026","article-title":"A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment Study","volume":"151","author":"Krupin","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.ajo.2014.02.009","article-title":"Risk factors for optic disc hemorrhage in the low-pressure glaucoma treatment study","volume":"157","author":"Furlanetto","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/j.1532-5415.2010.02767.x","article-title":"Competing risk of death: an important consideration in studies of older adults","volume":"58","author":"Berry","year":"2010","journal-title":"J Am Geriatr Soc"},{"key":"bib43","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1093\/ije\/dyr213","article-title":"Competing risks in epidemiology: possibilities and pitfalls","volume":"41","author":"Andersen","year":"2012","journal-title":"Int J Epidemiol"},{"key":"bib9","first-page":"1","article-title":"Corolla: an efficient multi-modality fusion framework with supervised contrastive learning for glaucoma grading","volume-title":"2022 IEEE 19th International Symposium on Biomedical Imaging (ISBI). Kolkata, India, March 28\u201331","author":"Cai","year":"2022"},{"key":"bib10","first-page":"52","volume-title":"Clinical Decisions in Glaucoma","author":"Hodapp","year":"1993"},{"key":"bib18","article-title":"Calcium channel blockers","volume-title":"StatPearls","author":"McKeever","year":"2024"}],"container-title":["Investigative Ophthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.67.5.59","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:32:22Z","timestamp":1791927142000},"score":1,"resource":{"primary":{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.67.5.59"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,1]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.67.5.59","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,21]]}}}